A&P LIFESCIENCE FUND, FI
•CLASE C
Valor Liquidativo
Patrimonio
Cartera Renta Variable
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
US45253H1014 ImmunoGen Inc | EUR | 158.810 € | 4.44% | 245.62% |
US38000Q1022 GlycoMimetics Inc | EUR | 133.616 € | 3.73% | 2.94% |
US16961L1061 Chinook Therapeutics | EUR | 105.339 € | 2.94% | Nueva |
US81181C1045 Seattle Genetics Inc | EUR | 79.038 € | 2.21% | 46.96% |
US5324571083 Lilly (Eli) & Co. | EUR | 73.513 € | 2.05% | 37.89% |
US4622221004 Ionis Pharmaceutical | EUR | 72.740 € | 2.03% | 38.18% |
CH0334081137 CRISPR Therapeutics | EUR | 72.304 € | 2.02% | 280.07% |
US05464T1043 Axsome Therapeutics | EUR | 70.286 € | 1.96% | 8.57% |
US04280A1007 Arrowhead Pharmaceut | EUR | 67.142 € | 1.88% | 36.11% |
DE0006632003 Morphosys AG | EUR | 66.550 € | 1.86% | 70.14% |
US3723032062 Genmab A/S | EUR | 63.553 € | 1.78% | 8.83% |
US45665G3039 Infinity Pharmaceuti | EUR | 61.089 € | 1.71% | 84.6% |
US00847X1046 Agios Pharmaceutical | EUR | 60.903 € | 1.7% | 49.31% |
US4923271013 Keros Therapeutics I | EUR | 60.699 € | 1.7% | 397.49% |
US02043Q1076 Alnylam Pharmaceutic | EUR | 60.591 € | 1.69% | 21.57% |
US0327241065 AnaptysBio Inc | EUR | 58.564 € | 1.64% | 107.49% |
US87164F1057 Descom Inc | EUR | 58.441 € | 1.63% | 23.03% |
US00445A1007 ACELYRIN Inc | EUR | 57.475 € | 1.61% | Nueva |
US59045L1061 Mersana Therapeutics | EUR | 50.039 € | 1.4% | Nueva |
CH0499880968 ADC Therapeutics SA | EUR | 49.407 € | 1.38% | 3% |
US30063P1057 Exact Sciences Corp | EUR | 47.600 € | 1.33% | 113.09% |
US04016X1019 ARGENX SE | EUR | 47.158 € | 1.32% | 0.95% |
US75943R1023 Relay Therapeutics I | EUR | 46.169 € | 1.29% | 761.52% |
US0311621009 Amgen Inc. | EUR | 43.350 € | 1.21% | 5.01% |
NL0010696654 Uni-Pixel Inc. | EUR | 43.102 € | 1.2% | 50.39% |
US45337C1027 IncytCor | EUR | 43.025 € | 1.2% | 1.64% |
US24823R1059 Denali Therapeutics | EUR | 40.468 € | 1.13% | 58.95% |
US45720L1070 Inhibrx Inc | EUR | 39.812 € | 1.11% | 64.11% |
US0197701065 AllogeneTherapeutics | EUR | 35.149 € | 0.98% | 34.61% |
US60468T1051 Mirati Therapeutics | EUR | 34.875 € | 0.97% | 19.07% |
US03969F1093 Arcus Biosciences In | EUR | 34.610 € | 0.97% | 29.08% |
US50127T1097 Kura Oncology Inc | EUR | 34.303 € | 0.96% | Nueva |
US65487U1088 Nkarta Inc | EUR | 34.039 € | 0.95% | 32.78% |
US07725L1026 Beigene ltd-adr | EUR | 33.506 € | 0.94% | 1.93% |
US52490G1022 Legend Biotech Corp | EUR | 33.284 € | 0.93% | 38.79% |
US70975L1070 Penumbra Inc | EUR | 33.116 € | 0.93% | 69.53% |
US0028241000 Abbott Laboratories | EUR | 33.379 € | 0.93% | 30.71% |
US7291391057 Pliant Therapeutics | EUR | 32.373 € | 0.9% | 35.1% |
US09077A1060 Biomea Fusion Inc | EUR | 31.912 € | 0.89% | 155.52% |
US8036071004 Sarepta Therapeutics | EUR | 30.968 € | 0.87% | 7.64% |
US1011371077 Accs. Boston Scienti | EUR | 30.543 € | 0.85% | 19.77% |
US67080M1036 Nurix Therapeutics I | EUR | 29.909 € | 0.84% | Nueva |
US98401F1057 Xencor Inc | EUR | 29.848 € | 0.83% | 40.88% |
US76029N1063 Replimune Group Inc | EUR | 29.267 € | 0.82% | 43.8% |
US00166B1052 ALX Oncology Holding | EUR | 28.845 € | 0.81% | 33.85% |
US45166A1025 Ideaya Biosciences I | EUR | 28.414 € | 0.79% | 90.44% |
US45781K2042 Innate Pharma SA | EUR | 27.818 € | 0.78% | 5.27% |
IE00BTN1Y115 Medtronic INC | EUR | 27.943 € | 0.78% | 40.47% |
US66987V1098 NOVARTIS AG-REG SHS | EUR | 27.473 € | 0.77% | 20.51% |
US03890D1081 Aravive Inc | EUR | 27.072 € | 0.76% | 16.36% |
US92686J1060 Viking Therapeutics | EUR | 27.014 € | 0.75% | Nueva |
US00653A1079 Adaptimmune Therapeu | EUR | 25.237 € | 0.71% | 21.27% |
US8835561023 Thermo Electron Corp | EUR | 25.349 € | 0.71% | 7.02% |
US8006771062 Sangamo Therapeutics | EUR | 24.967 € | 0.7% | 58.38% |
US00287Y1091 AbbVie Inc | EUR | 24.207 € | 0.68% | 8.37% |
US4497781090 IO Biotech Inc | EUR | 23.227 € | 0.65% | 0.18% |
US75886F1075 Regeneron Pharmaceut | EUR | 23.053 € | 0.64% | 3.65% |
US7711951043 ROCHE HOLDING | EUR | 22.691 € | 0.63% | 4.25% |
US05153U1079 Aura Biosciences Inc | EUR | 22.359 € | 0.62% | 63.41% |
US0327973006 Anavex Life Sciences | EUR | 22.291 € | 0.62% | 40.9% |
US04335A1051 Arvinas Inc | EUR | 22.001 € | 0.61% | 5.11% |
NL0010872420 Affimed NV | EUR | 20.408 € | 0.57% | 25.87% |
US09061G1013 Biostar Pharmaceutic | EUR | 20.421 € | 0.57% | 63.71% |
US68236P1075 Oncternal Therapeuti | EUR | 19.710 € | 0.55% | Nueva |
US73730P1084 Poseida Therapeutics | EUR | 19.849 € | 0.55% | 57.51% |
US09075P1057 Bioxcel Therapeutics | EUR | 19.121 € | 0.53% | 36.34% |
US89422G1076 Travere Therapeutics | EUR | 18.755 € | 0.52% | Nueva |
US09609G1004 Bluebird Bio Inc | EUR | 18.581 € | 0.52% | 0.12% |
US46565G1040 iTeos Therapeutics I | EUR | 16.312 € | 0.46% | 8.64% |
US40131M1099 Guardant Health Inc | EUR | 15.194 € | 0.42% | 81.2% |
US3441741077 Foghorn Therapeutics | EUR | 13.984 € | 0.39% | 33.24% |
US05280R1005 Autolus Therapeutics | EUR | 11.159 € | 0.31% | 65.44% |
US00461U1051 Aclaris Therapeutics | EUR | 11.150 € | 0.31% | 44.8% |
US4523271090 Illumina Inc | EUR | 9625 € | 0.27% | 9% |
US31189P1021 Fate Therapeutics In | EUR | 8138 € | 0.23% | 53.71% |
US09077B1044 BioAtla Inc | EUR | 7202 € | 0.2% | 45.89% |
US28106W1036 Edit-Me | EUR | 7076 € | 0.2% | 53.33% |
US0887861088 Bicycle Therapeutics | EUR | 6503 € | 0.18% | 18.78% |
US14147L1089 Cardiff Oncology Inc | EUR | 6359 € | 0.18% | 54.23% |
US75082Q1058 Rain Oncology Inc | EUR | 4734 € | 0.13% | Nueva |
US46124U1079 Inventiva SACA | EUR | 4748 € | 0.13% | 90.22% |
US45175G1085 Ikena Oncology Inc | EUR | 4378 € | 0.12% | 142.01% |
US55910K1088 Magenta Therapeutics | EUR | 4370 € | 0.12% | 88.28% |
US0076244062 Advaxis Inc | EUR | 2369 € | 0.07% | Nueva |
US7027121000 Passage Bio Inc | EUR | 2244 € | 0.06% | 10.67% |
US1894641000 Clovis Oncology Inc | EUR | 201 € | 0.01% | 78.22% |
US05465V1089 Ayala Pharmaceutical | EUR | 0 € | 0% | Vendida |
IL0010852080 Compugen Ltd | EUR | 0 € | 0% | Vendida |
Cartera ICC
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
IE00BQ70R696 Invesco NASDAQ Biote | EUR | 155.184 € | 4.34% | Nueva |
IE00BQ70R696 ETFEner | EUR | 0 € | 0% | Vendida |
2023-Q2
Renta Variable Internacional
EUR
0
0
0
0 €
0 €
Política de Inversión
Operativa con derivadosSe podrá operar con instrumentos financieros derivados negociados en mercados organizados y no organizados de derivados con la finalidad de cobertura y de inversión.
Sectores
- Salud
98.12%
- No Clasificado
1.88%
Regiones
- Estados Unidos
90.84%
- Europa
9.16%
Tipo de Inversión
- Small Cap - Growth
25.41%
- Small Cap - Value
23.07%
- Small Cap - Blend
15.81%
- Medium Cap - Growth
10.17%
- Large Cap - Growth
6.32%
- Large Cap - Blend
6.01%
- Medium Cap - Value
2.37%
- Medium Cap - Blend
2.00%
- Large Cap - Value
1.71%
- No Clasificado
7.15%
Comisiones
Comisión de gestión
Total0.00
Comisión de depositario
Total0.00